Compass Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-286
Closed -$93.7K 63
2025
Q4
$93.7K Buy
286
+2
+0.7% +$634 0.04% 70
2025
Q3
$80.2K Buy
284
+2
+0.7% +$580 0.04% 80
2025
Q2
$78.8K Sell
282
-19
-6% -$5.38K 0.04% 72
2025
Q1
$93.7K Buy
301
+38
+14% +$11.2K 0.05% 57
2024
Q4
$68.5K Buy
+263
New +$78K 0.04% 55

Other funds holding AMGN

Compass Financial Services's AMGN Position: Q1 2026 in Review

Compass Financial Services sold out of Amgen (AMGN) in Q1 2026, closing a stake of 286 shares — an estimated $93.7K sold.

Compass Financial Services first reported a position in AMGN in Q4 2024 and held it in 5 quarters. The position peaked at $93.7K in Q1 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Compass Financial Services reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Compass Financial Services sold 286 Amgen shares in Q1 2026, an estimated $93.7K.
  • Compass Financial Services first reported a position in Amgen in Q4 2024 and held it in 5 quarters.
  • Compass Financial Services's Amgen position peaked at $93.7K in Q1 2025.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Compass Financial Services's 13F filing for Q1 2026, filed 1 May 2026.